A6205612
Nortadalafil , ≥98% , 171596-36-4
| Pack Size | Price | Stock | Quantity |
| 25MG | RMB514.40 | In Stock |
|
| 100MG | RMB1412.80 | In Stock |
|
| 500MG | RMB4952.80 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 285-290℃ (methanol ) |
| Boiling point: | 718.6±60.0 °C(Predicted) |
| Density | 1.55±0.1 g/cm3(Predicted) |
| storage temp. | Inert atmosphere,Room Temperature |
| solubility | DMSO (Slightly), Methanol (Slightly, Sonicated) |
| form | Solid |
| pka | 13.53±0.40(Predicted) |
| color | White to Pale Yellow |
| InChI | InChI=1S/C21H17N3O4/c25-18-9-22-21(26)15-8-13-12-3-1-2-4-14(12)23-19(13)20(24(15)18)11-5-6-16-17(7-11)28-10-27-16/h1-7,15,20,23H,8-10H2,(H,22,26)/t15-,20-/m1/s1 |
| InChIKey | XHDLVMPUSXRZOS-FOIQADDNSA-N |
| SMILES | N1C2=C(C=CC=C2)C2C[C@]3([H])C(=O)NCC(=O)N3[C@H](C3=CC=C4OCOC4=C3)C1=2 |
Description and Uses
A N-desmethyl analogue of the human PDE5 inhibitor Tadalafil (T004500). A potential antiplasmodial drug.
Safety
| Symbol(GHS) | ![]() ![]() ![]() GHS05,GHS07,GHS09 |
| Signal word | Danger |
| Hazard statements | H302+H312-H314-H317-H410 |
| Precautionary statements | P501-P273-P272-P260-P270-P264-P280-P391-P362+P364-P303+P361+P353-P333+P313-P301+P330+P331-P301+P312+P330-P304+P340+P310-P305+P351+P338+P310-P405 |






![(1S,3R)-1-Benzo[1,3]dioxol-5-yl-2-(2-chloro-acetyl)-2,3,4,9-tetrahydro-1H-b-carboline-3-carboxylic Acid Methyl Ester](https://img.chemicalbook.com/CAS/GIF/629652-40-0.gif)
![(1R,3S)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester](https://img.chemicalbook.com/CAS/GIF/629652-44-4.gif)
![(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester](https://img.chemicalbook.com/CAS/GIF/171596-43-3.gif)
![(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester](https://img.chemicalbook.com/CAS/GIF/629652-42-2.gif)